The Roswell Park GMP Engineering & Cell Manufacturing Facility, or Roswell Park GEM, is the largest academic cell and gene therapy research and manufacturing facility in the U.S., according to a Dec. 16 news release from the cancer center.
One of the facility’s focuses will be developing cell and gene therapies to treat solid-tumor cancers, the release said.
Roswell Park recently appointed Michael Wong, MD, PhD, to serve as the center’s first physician-in-chief and is set to launch an oncology nurse scientist training program with a $2.11 million grant from the National Cancer Institute.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
